Prostate Cancer - Results from #25200

Prostate cancer - the role of magnetic resonance imaging - Abstract August 28, 2012

Acorda Therapeutics announces GGF2 preclinical data on treatment of erectile dysfunction August 28, 2012

Implementation and scientific evaluation of rehabilitative sports groups for prostate cancer patients: Study protocol of the ProRehab Study - Abstract August 27, 2012

Associations between testosterone levels and incident prostate, lung, and colorectal cancer. A population-based study - Abstract August 27, 2012

A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer - Abstract August 27, 2012

Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging - Abstract August 27, 2012

Redefining micrometastasis in prostate cancer - a comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatecto August 27, 2012

Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant - Abstract August 27, 2012

High-dose 3D-CRT in the radical and postoperative setting for prostate cancer. Analysis of survival and late rectal and urinary toxicity - Abstract August 27, 2012

A case of small cell carcinoma of the prostate and review of the literature - Abstract August 27, 2012

Informed decision making about prostate cancer testing in predominantly immigrant black men: A randomized controlled trial - Abstract August 27, 2012

Neighbourhoods matter too: The association between neighbourhood socioeconomic position, population density and breast, prostate and lung cancer incidence in Denmark between 2004 and 2008 - Abstract August 27, 2012

Molecular imaging of prostate cancer: PET radiotracers - Abstract August 27, 2012

The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: Effect of reader experience - Abstract August 27, 2012

Atypical metastases from prostate cancer: 10-Year experience at a single institution - Abstract August 27, 2012

A changing landscape in castration-resistant prostate cancer treatment - Abstract August 27, 2012

Prostate cancer dependance upon cholesterol, statins and diet - Abstract August 27, 2012

Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy - Abstract August 25, 2012

Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer - Abstract August 25, 2012

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy - Abstract August 25, 2012

Page 1261 of 1447